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Synopsis
Animal replication-dependent histone genes produce histone proteins for the packaging of newly replicated genomic
DNA. The expression of these histone genes occurs during S phase and is linked to DNA replication via S-phase check-
points. The histone RNA-binding protein HBP/SLBP (hairpin-binding protein/stem-loop binding protein), an essential
regulator of histone gene expression, binds to the conserved hairpin structure located in the 3′UTR (untranslated re-
gion) of histone mRNA and participates in histone pre-mRNA processing, translation and histone mRNA degradation.
Here, we report the accumulation of alternatively spliced HBP/SLBP transcripts lacking exons 2 and/or 3 in HeLa
cells exposed to replication stress. We also detected a shorter HBP/SLBP protein isoform under these conditions
that can be accounted for by alternative splicing of HBP/SLBP mRNA. HBP/SLBP mRNA alternative splicing returned
to low levels again upon removal of replication stress and was abrogated by caffeine, suggesting the involvement of
checkpoint kinases. Analysis of HBP/SLBP cellular localization using GFP (green fluorescent protein) fusion proteins
revealed that HBP/SLBP protein and isoforms lacking the domains encoded by exon 2 and exons 2 and 3 were found
in the nucleus and cytoplasm, whereas HBP/SLBP lacking the domain encoded by exon 3 was predominantly local-
ised to the nucleus. This isoform lacks the conserved region important for protein–protein interaction with the CTIF
[CBP80/20 (cap-binding protein 80/20)]-dependent initiation translation factor and the eIF4E (eukaryotic initiation
factor 4E)-dependent translation factor SLIP1/MIF4GD (SLBP-interacting protein 1/MIF4G domain). Consistent with
this, we have previously demonstrated that this region is required for the function of HBP/SLBP in cap-dependent
translation. In conclusion, alternative splicing allows the synthesis of HBP/SLBP isoforms with different properties
that may be important for regulating HBP/SLBP functions during replication stress.
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INTRODUCTION
Eukaryotic chromatin is composed of DNA and histone pro-
teins. The correct chromatin structure is essential for cell di-
vision and gene expression. In animals, the chromatin struc-
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ture is maintained during DNA replication by S-phase-limited
expression of the replication-dependent histone genes (from
here on referred to simply as ‘histone’ genes). Animal his-
tone genes produce mRNAs that are not polyadenylated; in-
stead they contain a highly conserved hairpin structure at their 3′
ends.
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Histone proteins are only produced during S phase of the cell
cycle. The expression of histone genes is co-ordinately regulated
and finely balanced with DNA replication and disturbing this bal-
ance can severely affect genomic stability and gene expression by
inducing DNA damage and replication fork collapse [1,2]. At the
level of RNA, three major processes: transcription, mRNA 3′ end
processing and mRNA stability control contribute to the complex
regulation of histone gene expression during S phase [3,4]. This
combination of transcriptional and post-transcriptional control
acts to regulate the 35-fold increase of histone mRNA levels as
cells progress from G1 into S phase and ensures that the mRNA
levels return to baseline levels as the cells exit S phase [5].
In metazoans, the majority of this cell cycle regulation is car-
ried out post-transcriptionally and is predominantly mediated by
the conserved RNA hairpin element and its trans-acting bind-
ing partner the HBP/SLBP (hairpin-binding protein/stem-loop-
binding protein) [6,7]. The gene-encoding human HBP/SLBP is
located on chromosome 4 (4p16.3) and has an 810 nt (nucleotide)
ORF (open reading frame) distributed over eight exons, which
generates a 270 amino acid protein [8].
HBP/SLBP expression itself is also cell cycle regulated. In
human cells, the intracellular concentration of HBP/SLBP in
cycling cells is not detectable in G1 phase but begins to accu-
mulate at the G1/S phase transition and remains at a high level
during S phase [9]. At the end of S phase, it is degraded by the
proteasome pathway and is not detectable again until the G1/S
phase boundary. Therefore it accumulates and is degraded in par-
allel to histone mRNAs. It has been suggested that the increase
in HBP/SLBP abundance is because of a combination of a 2-
fold increase in transcription rate combined with an increase in
the rate of translation in S phase, but there is no direct evidence
for this. The degradation at the end of S phase is thought to be
triggered by protein phosphorylation at several sites including the
Thr61Thr62Pro63 motif in the N-terminal domain of HBP and oc-
curs by the ubiquitin–proteasome pathway [10,11]. The degrad-
ation of HBP/SLBP is temporally linked to the disappearance of
histone mRNAs from the cell. The absence of HBP/SLBP outside
S phase prevents 3′ end processing of histone pre-mRNAs and
restricts the generation of mature histone transcripts to S phase.
However, histone mRNA is still destabilised upon exit from S
phase even in cells that cannot degrade HBP/SLBP due to ex-
posure to a proteasome inhibitor or expression of a stabilised
HBP/SLBP protein [12]. Despite the fact that in such experi-
ments HBP/SLBP was generally expressed from a plasmid, these
findings are compatible with there being no direct link between
HBP/SLBP levels and histone mRNA stability reported to date.
Localization studies have shown that HBP/SLBP can be found
in both the nucleus and the cytoplasm, consistent with its known
roles in histone pre-mRNA processing in the nucleus and their
subsequent translation in the cytoplasm [13].
HBP/SLBP binds to histone pre-mRNA in the nucleus and
participates in histone mRNA 3′ end processing. It undergoes
interactions with ZFP100, a component of the U7 snRNP (small
nuclear ribonucleoprotein); another factor involved in histone
RNA 3′ end processing that determines the position of the cleav-
age site [14,15]. The RNA CPSF (cleavage and polyadenylation
specificity factor)-73 is recruited to the cleavage site by associ-
ation with the U7snRNP [16]. After processing, the mature his-
tone transcripts are exported to the cytoplasm with HBP/SLBP
still bound to the hairpin element at the 3′ end. The histone RNA
hairpin element has been shown to be important for nuclear ex-
port [17,18], but any involvement of HBP/SLBP in this process
is less clear. Using Xenopus laevis oocytes as an experimental
system, it was found that histone mRNA export was independent
of SLBP, but a more recent report utilizing an artificial nuclear
export assay in human cells suggests that human HBP/SLBP may
be involved in this process [19,20].
In the cytoplasm, HBP/SLBP stimulates translation of histone
mRNAs [21–23]. HBP/SLBP is thought to interact with a histone
mRNA specific translation factor called SLIP1 (SLBP-interacting
protein 1, or MIF4GD (MIF4G domain)-containing protein) as
well as with eIF3 (eukaryotic initiation factor 3) and PAIP1
(polyadenylate-binding protein-interacting protein 1) [21,22,24].
It has been proposed that HBP/SLBP binds SLIP1 that in turn
binds the 5′ cap-binding protein, eIF4E and hence circularises the
mRNA. SLIP1 binds to Xenopus SLBP1 via a conserved 15 amino
acid region known to be critical for activation of histone mRNA
translation [21,23]. SLIP1 also interacts with eIF4G, possibly in
the same region as the PABP (poly(A) binding protein) binds
[21], indicating that SLIP1 promotes translational efficiency in
much the same way that PABP acts in the translation of poly-
adenylated transcripts. Lately, human HBP/SLBP was found to
interact with the CTIF [CBP80/20 (cap-binding protein 80/20)-
dependent initiation translation factor)] [25]. CTIF is involved in
the first, pioneer round of translation, taking place directly after
nuclear export of mRNA [25,26]. The conserved region found to
be important for translation in Xenopus SLBP1 is also implicated
in the interaction with CTIF.
The synthesis of histones and the production of DNA are intim-
ately coupled and disrupting either histone production or DNA
replication results in the inhibition of the other process. It is very
likely that the signals involved in linking histone gene expres-
sion and DNA replication act at various levels to ensure they
are tightly regulated. Some of this complex coupling is mediated
by a poorly understood checkpoint involving the protein kinases
ATR [ATM (ataxia telangiectasia mutated)- and Rad3-related]
and DNA-PK (DNA-dependent protein kinase) [27,28]. This in-
cludes the rapid degradation of histone mRNAs induced under
replication stress conditions. For a long time it was believed that
HBP/SLBP was not involved in the stability control of histone
mRNAs because while histone mRNAs rapidly disappear when
replication is inhibited, HBP/SLBP remains stable until the end
of S phase. Indeed, some of these factors have been shown to be
required for histone mRNA decay [29]. In addition, the expres-
sion of HBP/SLBP unable to undergo an interaction with CTIF
delayed the replication stress-induced decay of histone mRNA,
implicating CBP80/20-mediated translation in histone mRNA
decay [25]. Other factors involved in histone mRNA degradation
following DNA replication inhibition include LSM1 and UPF1
[27,29] and the latter has been linked to DNA replication and
to various nuclear events independent of its role in nonsense-
mediated mRNA decay [30].
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Replication stress-induced alternative mRNA splicing
Here we report the identification and characterization of al-
ternative HBP/SLBP mRNA splice variants that can be detected
at the RNA and protein level under replication stress conditions.
The stress-induced alternative splicing affected exons coding for
domains with important functions in histone mRNA translation
and HBP/SLBP localization and stability. We observed that this
increase in alternative splicing under replication stress conditions
was abrogated by the checkpoint kinase inhibitor caffeine. We
also analysed the effect of alternative splicing on the cellular loc-
alization of HBP/SLBP isoforms using GFP (green fluorescent
protein) fusion proteins. Our observations indicate that alternative
splicing of HBP/SLBP mRNA may contribute to the regulation
of histone gene expression; for example, during replication stress
conditions by allowing for the synthesis of HBP/SLBP proteins
with tailored functional properties.
MATERIALS AND METHODS
Cell culture
HeLa cells were grown in DMEM (Dulbecco’s modified Eagle’s
medium) supplemented with 10 % (v/v) FBS (fetal bovine serum)
at 37 ◦C in a 5 % (v/v) CO2 atmosphere. Cells were synchronised
at G1/S phase transition by double thymidine block. Treatment
with HU (hydroxyurea) was at 2 mM. Treatment with 5 mM
caffeine (Sigma-Aldrich) for 1 h prior to the addition of HU was
performed as previously described [28].
Plasmids
A HBP/SLBP fragment containing the HBP/SLBP ORF
immediately preceded by an EcoRI site was released from
pCI-neo-N-HA [31,32] by restriction with EcoRI and DraI
and inserted into pEGFP-C2 (Clontech) cleaved with EcoRI
and SmaI. Exons 2 and/or 3 were deleted from this con-
struct by site-directed mutagenesis using the QuikChange
Lightning mutagenesis kit (Agilent Technologies) with
primer CGACGGTGACGCCAGCTTTACCACTCCTGAAG-
GCCC and its reverse complement for deletion of exon 2; primer
GTCATTGATGAGGAGTTTCCTTTTATATCTCTCGGGTCT-
GCGCTC and its reverse complement for deletion of
exon 3; primer GCGACGGTGACGCCAGATATAAAAG-
GAAACTCCTCATCAATGACTTTG and its reverse comple-
ment for deletion of exons 2 and 3. All constructs were analysed
by DNA sequencing (DNA Sequencing & Services, Dundee
University).
Analysis of alternative splicing of HBP/SLBP mRNA
by semi-QPCR (quantitative PCR)
RNA was prepared by extraction with TRIzol (Life Technolo-
gies). Normally, 2 μg total RNA was reverse transcribed us-
ing random primers and MMLV (Moloney murine leukaemia
virus) RT (reverse transcriptase) (Promega) according to the
manufacturer’s instructions. Alternative splicing of HBP/SLBP
was detected by PCR using primers CCGCCGAGGCATCA-
GAGC (primer binding site in exon 1) and AAGCTTCCAAAT-
CAAACTCATCCTCCAC (primer binding site in exon 8) and
GoTaq DNA polymerase (Promega). PCR reactions were per-
formed as recommended by the manufacturer and cycling con-
ditions were 5 min at 94 ◦C, followed by 40 cycles of 30 s at
94 ◦C, 30 s at 64 ◦C and 1 min at 72 ◦C, followed by a final
10 min at 72 ◦C. PCR reactions were analysed by agarose gel
electrophoresis and the DNA was detected by ethidium bromide
staining. Images were captured and analysed using Gene Tools
(Syngene). The frequency of alternative splicing was calculated
without compensating for the different lengths of the fragments.
To confirm that the bands represent alternative spliced forms of
HBP/SLBP mRNA, the PCR products were isolated, cloned into
pGEM-T Easy (Promega) and sequenced (DNA Sequencing &
Services, Dundee University).
To detect alternative splicing of β-tubulin mRNA
(NM_178014.2), primers GGTGCCAAGTTCTGGGAGGTG
and GGAAACGGAGGCAGGTGGTG were used for PCR.
Primer binding sites are located to sequences in the first and
last exon (exon 4) of this transcript, and a 679 bp (base pairs)
PCR product contains all exons. To detect alternative splicing of
GAPDH (glyceraldehyde-3-phosphate dehydrogenase) mRNA
(NM_002046.3), primers TGGGGAAGGTGAAGGTCGGAG
and CTCTTGCTGGGGCTGGTGG were used. Primer binding
sites are located in exon 2, which contains the start of the ORF,
and the last exon (exon 9). The full length PCR product spanning
exons 2–9 is expected to be 1017 bp in length. ZFP100 (ZNF473)
was detected using primers CGTGTGCGGGGAGTTGAATC
and CCAGGTGTCCTCTATACAGGCTTCTCC. Primer bind-
ing sites are located in exons 1 and 5, which is the last
exon. These primers detect ZFP100 transcript variants 1 and 2
(NM_015428.1; NM_001006656.1), and produce 631 and 509 bp
PCR products, respectively. The PCR products were isolated,
cloned into pGEM-T Easy (Promega) and their identity was con-
firmed by sequencing (DNA Sequencing & Services, Dundee
University).
SDS/PAGE and Western blotting
Cell lysates were prepared by cell lysis using RIPA buf-
fer supplemented with protease inhibitors (Roche). Proteins
(20 μg/sample), along with a pre-stained marker (ColorPlusTM
Prestained Protein Ladder from New England Biolabs) were
separated by SDS/12%PAGE. Proteins were transferred onto
Hybond-P membrane (GE Healthcare). HBP/SLBP was detec-
ted using affinity purified anti HBP/SLBP serum. The serum
was used previously [33] and was purified by binding to human
His-tagged recombinant HBP/SLBP expressed in insect cells us-
ing a baculovirus protein expression system and immobilised on
Hybond-N membrane (GE Healthcare). The bound antibody was
eluted with 200 mM glycine, pH 2.8, and the pH of the eluate was
then adjusted to pH 7.5 with 1M Tris base, and supplemented with
1 % (w/v) BSA. Antibody staining was detected by chemilumin-
escence (ECL Plus Western Blotting Detection Reagents or kit,
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GE Healthcare), using HRP (horseradish peroxidase)-coupled
anti-mouse or anti-rabbit secondary antibodies (Cell Signalling)
and Kodak MXB films.
Northern blotting
Northern blotting was performed as described previously [28].
HBP/SLBP mRNA was detected using a 460 bp probe spanning
nts 416–876 (exons 4–8) prepared by PCR amplification from
HBP/SLBP cDNA. RNA was visualized using Kodak MXB films
or using a FujiFilm FLA-3000 Image Analyser and analysed
using AIDA software.
Microscopy
Plasmids expressing GFP fusion proteins were transfected into
HeLa cells growing on cover slips. Cells were synchronised
by double thymidine block, and transfected during the period
between the first and second thymidine treatment. Following the
second block, the cells were either released into S phase for 4 h
or they were released for 3 h followed by a 1 h treatment with
5 mM HU to degrade histone mRNA (4 h total post-release). For
visualization, 4 h after release from the second thymidine block,
the cells were fixed with 4 % (v/v) PFA (paraformaldehyde) and
the cover slips were mounted with Vecta-Shield mounting me-
dium containing DAPI (4′,6-diamidino-2-phenylindole) and fi-
nally analysed using a Zeiss LSM 700 laser scanning microscope
with ZEN software (Zeiss). For this analysis, exposures were
adjusted for background fluorescence levels using untransfected
cells.
RESULTS
Alternative splicing of HBP/SLBP transcripts gives
rise to several mRNAs and proteins
The RNA-binding protein HBP/SLBP is a central regulator that
co-ordinates the expression of all histone genes. HBP/SLBP is
essential for histone mRNA 3′ end formation and is involved in
translation of histone mRNA, as well as playing a role in the
control of histone mRNA stability [6,7]. A bioinformatic survey
of human HBP/SLBP sequences led to the identification of two
alternatively spliced variants; a variant that lacks exon 3 and one
that lacks exon 2 out of a total of eight exons (Figure 1). Both
sequences were present in the NCBI (National Centre for Bio-
technology Information) EST database. The human variant lack-
ing exon 3 is represented by BG614662, CN398104, DC360271,
DC387327, DC424059 and HY180290 found in RNA isolated
from testicular embryonal carcinoma, embryonic stem cells,
neuroblastoma, embryos and mixed human RNA samples. The
variant lacking exon 2 encoded by DA564172 was found in RNA
isolated from heart tissue. Exons 2 and 3 encode elements found
to be important for HBP/SLBP nuclear localization and degrada-
tion as well as histone mRNA translation but not for RNA binding
[12,13,22,23,34] (see also Figure 4 below). Therefore alternative
splicing is expected to produce proteins with altered properties.
We wanted to determine whether we could detect alternative spli-
cing of HBP/SLBP mRNA. In dividing cells, alternative splicing
is rare and has not been reported. To explore whether alternative
splicing may occur in cells subjected to replication stress condi-
tions we compared HBP/SLBP mRNA structure in S-phase HeLa
cells and in S-phase HeLa cells treated with the DNA replication
inhibitor HU (hydroxyurea). HU is an inhibitor of ribonucleotide
reductase. Treatment with this compound prevents the dNTP pool
expansion that normally occurs at the G1/S phase boundary and
causes replication stress conditions. Treatment with HU is also
known to lead to the termination of histone gene expression in S
phase cells (see e.g. [28]). RNAs were analysed by Northern blot-
ting (Figure 1A). HBP/SLBP mRNA isolated from S-phase cells
migrated as expected with the mobility of about 1.9 kb (kilobase)
mRNA [8]. In RNA prepared from cells treated with HU, the
majority of HBP/SLBP mRNA migrated with the same mobility
but we also detected some HBP/SLBP mRNA with increased
mobility shown by the arrow in Figure 1(A).
We decided to investigate whether the appearance of the faster
migrating HBP/SLBP mRNA was really because of alternative
splicing of HBP/SLBP mRNA. We designed a semi-quantitative
PCR-based assay with PCR primers located in the first and last
exon of HBP/SLBP (exons 1 and 8, respectively; Figure 1B).
PCR amplification of full-length cDNA containing all eight ex-
ons produces a 752 bp fragment while alternatively spliced tran-
scripts produce shorter PCR products. The analysis of splicing
using cDNA prepared from total RNA isolated from HeLa cells
in S phase, followed by PCR amplification and agarose gel elec-
trophoresis (Figure 1C), produced predominately approximately
750 bp long fragments (90.7 %) and a small proportion of ap-
proximately 640 bp long fragments (9.3 %), compatible with the
majority being full length HBP/SLBP transcripts and a minority
of alternatively spliced transcripts, respectively. The length of
the minor species of PCR products is compatible with mRNAs
lacking exons 2 or 3 (635 bp and 646 bp, respectively). The
identities of the PCR products were determined by cloning into
pGEM-T Easy followed by Sanger sequencing analyses. This
confirmed that the 750 bp products corresponded as expected
to full-length HBP/SLBP transcripts, while the shorter fragment
matched with the HBP/SLBP mRNA splice variant lacking exon
3. From here on, we refer to these splice variants as HBP/SLBP
and HBP/SLBPE3, respectively.
We compared this observation to splicing occurring in cells
treated with HU (Figure 1C). In RNA prepared from cells treated
with HU for 3 h we detected approximately 750 bp long frag-
ments (62.8 %) and an increased amount of approximately 640 bp
long fragments (25.6 %) corresponding to HBP/SLBPE3 or
possibly to HBP/SLBP lacking exon 2 (HBP/SLBPE2). Ad-
ditionally, we detected another PCR product of about 500 bp
(11.6 %). Products of this length (530 bp) are expected for a
transcript lacking both exons 2 and 3. The identities of these
PCR products were determined by sequencing analyses. As ex-
pected, approximately 750 bp long fragments were full length
HBP/SLBP mRNAs. The approximately 500 bp long fragments
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Replication stress-induced alternative mRNA splicing
Figure 1 Alternative splicing of HBP/SLBP transcripts
(A) Analysis of HBP/SLBP mRNA by Northern blotting. Total RNA was isolated from HeLa cells synchronised by dT (double
thymidine) block and released into S phase for 6 h (S phase), and from S-phase HeLa cells released into S phase for 3 h
and then treated with HU for a further 3 h ( + HU). The arrow indicates HBP/SLBP RNA with increased mobility. RNA size
standards are indicated in kb. (B) Schematic representation of HBP/SLBP splice variants generated by skipping of exons
2 and/or 3. The lengths of PCR products with primers (black arrows) used to detect alternative splicing are indicated. (C)
Analysis of HBP/SLBP mRNA splicing by semi-quantitative PCR. RNA prepared from S phase HeLa cells and S phase HeLa
cells treated for 3 h with + HU was reverse transcribed using random primers. HBP/SLBP splice variants were amplified
by PCR from cDNA and analysed by agarose gel electrophoresis as described in Materials and Methods. HBP/SLBP mRNA
splice variants are indicated. M indicates the molecular markers, with the size in bp. (D) Analysis of HBP/SLBP proteins.
Lysates prepared from HeLa cells 6 h after release into S phase and HeLa cells released into S phase and after 3 h treated
with + HU for a further 3 h were analysed by Western blotting using affinity purified HBP/SLBP antibody.  indicates a weak
signal detected in both samples in the region where HBP/SLBPE2 +E3 would be expected. (E) Analysis of splicing of
GAPDH, β -tubulin and histone processing factor ZFP100 mRNAs. mRNA splicing was analysed as described in Materials
and Methods. ZFP100 tv (transcript variants) 1 and 2 were detected in both the RNA prepared from HeLa cells in S phase
and from S-phase HeLa cells treated for 3 h with HU. In addition, we detected a minor variant lacking exon 2 (). GAPDH
mRNA products spanning exons 2–9 and containing the ORF, and β -tubulin mRNA spanning exons 1–4 and containing the
ORF were detected in both RNA preparations. For clarity, pictures are shown in inversed colours. M indicates the molecular
markers.
did correspond to the splice variant lacking both exons 2 and
3 (hereafter named HBP/SLBPE2 +E3). This sequence is
also represented in the EST database (CR976286.1). Frag-
ments of approximately 640 bp which may correspond to either
HBP/SLBPE2 or HBP/SLBPE3 were also analysed. 89 % of
clones analysed represented HBP/SLBPE3 and the remaining
11.1 % matched to HBP/SLBPE2 mRNA (n = 18). This indic-
ates that the majority of these approximately 640 bp long frag-
ments represent the HBP/SLBPE3 splice variant mRNA. Note
that our findings do not rule out that HBP/SLBPE2 mRNA is
also present in S-phase cells, but the analysis above indicates that
this would occur at a low frequency. The ORFs are maintained in
HBP/SLBPE2, HBP/SLBPE3 and HBP/SLBPE2 +E3
transcripts, indicating that all these transcripts may encode
HBP/SLBP protein isoforms. We tested whether these splice
variants can be found in polysomes, and observed the association
of HBP/SLBP, HBP/SLBPE2 and HBP/SLBPE3 transcripts
and to a lesser degree of HBP/SLBPE2 +E3 transcripts with
ribosomes (results not shown), suggesting that these transcripts
may be translated.
Next, we established whether we could detect HBP/SLBP pro-
teins produced from alternatively spliced HBP/SLBP transcripts.
Using an affinity purified rabbit polyclonal anti-HBP/SLBP an-
tibody raised against the very C-terminus of HBP/SLBP [33] we
detected HBP/SLBP migrating as expected with the mobility of a
protein of about 42 kDa molecular mass (Figure 1D) in lysate pre-
pared from S-phase HeLa cells. This protein was also detected
in lysate prepared from S-phase HeLa cells treated with HU.
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In addition, we observed a smaller amount of a further
protein migrating with the mobility of a protein of about
37 kDa in S-phase HeLa cell lysate. The predicted mass dif-
ferences between HBP/SLBP and the isoforms lacking the do-
mains encoded by exon 2 or 3 or both exons 2 and 3, are
4.6 kDa, 4 kDa and 8.6 kDa, respectively. Thus, a mass dif-
ference of about 5 kDa is compatible with this faster migrat-
ing protein being HBP/SLBPE2 or HBP/SLBPE3, but not
HBP/SLBPE2 +E3. As the majority of transcripts analysed
in Figure 1(C) were the HBP/SLBPE3 splice variants we as-
sume that this is the predominant isoform. However, we cannot
exclude the possibility that we are actually detecting a mixture of
proteins composed of both isoforms. The HBP/SLBPE2 +E3
isoform is expected to migrate with the mobility of a pro-
tein of about 33 kDa. A comparison of the samples prepared
from cells treated with/without HU in Figure 1(D) indicates that
any amount of HBP/SLBPE2 +E3 protein produced in HU
treated cells was not significantly above the background sig-
nal also present in the protein sample from S-phase cells. This
indicates that the levels of HBP/SLBPE2 +E3 protein are
low, reflecting the relatively low abundance of this transcript
detected (Figure 1C). In conclusion, we have detected altern-
ative splicing of HBP/SLBP transcripts under replication stress
conditions, resulting in the synthesis of additional HBP/SLBP
isoforms.
Given that HBP/SLBP is predominately expressed during S
phase, during which it fulfils its functions in histone gene expres-
sion, we focused our further investigations on the link between
HBP/SLBP splicing and replication stress, which can be induced
by treatment with HU. First, it was important to examine whether
HU can cause widespread non-specific changes in mRNA spli-
cing patterns. To this end, we examined whether treatment with
HU can affect the splicing patterns of GAPDH mRNA, β-tubulin
mRNA or ZFP100 (or ZNF473) mRNA, using similar PCR assays
as employed for HBP/SLBP (Figure 1E), followed by sequence
analysis of the PCR products. ZFP100 was included because it
is specifically and directly involved in histone pre-mRNA pro-
cessing and, like HBP/SLBP, it is a component of the histone
pre-mRNA-processing complex [35]. The analysis of splicing in
HeLa cells treated with/without HU did not identify any signi-
ficant changes in the splicing pattern of these mRNAs. ZFP100
produces two major transcripts, transcript variants 1 and 2 dif-
fering in the length of exon 2. In transcript variant 2, the 5′ end
of exon 2 is lacking and its length is reduced from 199 to 77
nts, presumably due to alternative splicing. The major products
observed for ZFP100 were 631 bp and 509 bp long, as expec-
ted for transcript variants 1 and 2, respectively. A minor 431 bp
product (indicated by ↔ in Figure 1E) that represents a ZFP100
transcript variant lacking exon 2 completely was detected in cells
treated with and without HU. The products of GAPDH mRNA
and β-tubulin mRNA were of 1017 and 679 bp in length, respect-
ively, corresponding to mRNAs containing all known exons, as
confirmed by sequence analysis (Figure 1E). The relative propor-
tions of all these mRNAs were not significantly affected by the
treatment with HU. This indicates that alternative splicing is not
a general consequence occurring under replication stress condi-
tions and does not even apply to all factors specifically involved
in the control of histone gene expression.
HBP/SLBP mRNA alternative splicing is linked to
replication stress conditions and is abrogated by
treatment with caffeine
It is generally assumed that the full length HBP/SLBP pro-
tein encoded by the major transcript found in S-phase cells
is the form involved in the regulation of histone gene expres-
sion. The observation that HBP/SLBPE2, HBP/SLBPE3 and
HBP/SLBPE2 +E3 splice variants accumulate in HU-treated
cells indicated that replication stress conditions may enhance al-
ternative splicing of HBP/SLBP. Therefore we next examined in
more detail the correlation between the induction of replication
stress conditions and the effect that this has on the process of
HBP/SLBP mRNA splicing.
HeLa cells were synchronised by double thymidine block,
then released into S phase, and subsequently treated with/without
HU. In addition, HU was removed from the treated cells after an
extended exposure of 18 h, to allow for the resumption of DNA
replication (Figure 2A). An analysis of histone H2B mRNA levels
by Northern blotting showed that as expected histone H2B mRNA
disappeared rapidly after the addition of HU (Figure 2B) [28].
After 1 h, histone H2B mRNA levels were reduced to 13 % of the
level prior to addition of HU and remained low until the HU was
removed. Approximately 3 h after removal of HU, histone mRNA
levels had recovered to 48 %. This typical response of histone
H2B mRNA levels indicates that inhibition of DNA replication
leads to the inhibition of histone gene expression and that removal
of the inhibitor allows for restarting of DNA replication and thus
histone gene expression.
In parallel, we tested for HBP/SLBP mRNA alternative spli-
cing. We mainly detected full length transcripts in S-phase cells
and a small amount of HBP/SLBPE3 or HBP/SLBPE2 tran-
scripts (Figure 2B). Extrapolating from the bar chart summar-
izing the data from four independent experiments (Figure 2C),
the amount of these alternative splice variants increased approx-
imately 2-fold from 16 % in S-phase cells to 31 % after 18 h
exposure to HU and, intriguingly, after removal of HU, their
levels decreased again approximately 2-fold to 17 %. Strikingly,
the HBP/SLBPE2 +E3 splice variant was undetectable in
S-phase cells, and increased over time in the presence of HU,
reaching a peak (20 %) after 3 h of exposure. It decreased to nearly
undetectable levels (8 %) after removal of HU. Concurrently, the
proportion of full-length HBP/SLBP transcripts decreased from
83 % in S-phase cells to 50 % after prolonged exposure to HU,
and increased again to 75 % upon removal of HU. These findings
indicate that replication stress conditions do not silence the tran-
scription of the HBP/SLBP gene, but affect the splicing process.
In Figure 2(C), it can been seen that there are some minor dif-
ferences between experiments with regards to the proportion of
HBP/SLBP mRNAs being subject to alternative splicing. How-
ever, these results confirm that alternatively spliced forms lacking
exons 2 and/or 3 accumulate with time in the presence of HU,
and disappear after removal of HU. In summary, this indicates
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Figure 2 Alternative splicing of HBP/SLBP transcripts is linked to replication stress
(A) A depiction of the experimental timeline. HeLa cells were synchronised by dT block and released into S phase. After 3 h,
HU was added to cells for 18 h, then the HU was removed and the cells were incubated for a further 3 h. Time points when
samples were taken for analysis are indicated. (B) Analysis of histone gene expression and HBP/SLBP mRNA alternative
splicing. Top panel: analysis of HBP/SLBP mRNA splicing at indicated time points by reverse transcription followed by
PCR. Relevant size standard fragments are indicated (M). Bottom panels: Northern blot analysis of histone H2B mRNA
levels at the indicated time points. The blot was also probed for GAPDH mRNA. Histone mRNA levels were normalised with
respect to GAPDH mRNA levels, and histone mRNA levels in the absence of HU (S) were defined as 100 %. (C) The graph
summarises the quantification of the HBP/SLBP splice isoforms (expressed as % of total HBP/SLBP transcripts detected)
from four independent analyses of HBP/SLBP mRNA splicing. Shown are the means+−S.D..
that the alternative splicing of HBP/SLBP mRNA is influenced
by DNA replication and clearly increases under DNA replication
stress conditions.
We wanted to test whether alternative splicing of HBP/SLBP
mRNA in replication stress conditions may be dependent on
checkpoint function. We and others have demonstrated previ-
ously that treatment with HU causes cell cycle checkpoint activ-
ation leading to the rapid decay of histone mRNA by a mech-
anism that is not well understood [27,28]. To examine the pos-
sibility that HBP/SLBP mRNA splicing is similarly dependent
on checkpoint function we treated cells with caffeine, an inhib-
itor of the checkpoint kinases ATR and ATM. Although caffeine
has multiple pharmacological targets, it inhibits the ATM and
ATR kinases in vitro at concentrations close to those required
to sensitize cells to killing by DNA-damaging agents [36,37]. In
addition, caffeine blocks the radiation-induced ATM-dependent
phosphorylation of Chk2 on Thr68 [37]. Pre-treatment of cells
with 5 mM caffeine prior to the addition of HU led to a signi-
ficant reduction of HBP/SLBP mRNA alternative splicing com-
pared with splicing in cells treated with HU only (Figure 3). This
strongly suggests HBP/SLBP mRNA splicing being controlled
by caffeine-sensitive checkpoint kinases; however, the manner of
this control is unclear. It is possible that the kinases control the
activity of the splicing machinery, or act on other as yet uniden-
tified downstream factors.
Figure 3 Replication stress-induced alternative splicing of
HBP/SLBP mRNA is sensitive to caffeine
HeLa cells synchronised by dT block were treated with/without 5 mM
caffeine 3 h after release into S phase. After 1 h further incubation,
caffeine treated as well as untreated HeLa cells were treated with HU
for a further 3 h. Control cells (S phase) were left untreated. HBP/SLBP
mRNA splicing was analysed as described. M indicates the molecular
markers.
Alternative splicing produces HBP/SLBP proteins
lacking elements important for histone mRNA
stability control and translation
HBP/SLBP protein binds the conserved histone mRNA hairpin
element with high sequence specificity and affinity [38]. We and
others have previously shown that the RBD (RNA-binding do-
main) encoded by exons 5 and 6 is sufficient for RNA binding
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Figure 4 The exon structure and sequence elements in HBP/SLBP exons 1–4 are conserved in vertebrates
(A). Alignment of N-terminal regions of human, chicken and zebrafish HBP/SLBP and Xenopus SLBP1. Identical and similar
amino acids are indicated with stars and dots, respectively. Regions encoded by exons 2 and 4 are boxed in black, with
exon 3 in between. Amino acids boxed in grey are encoded by triplets spanning exon junctions. Residues of Xenopus
SLBP1 important for translation are underlined [21,23], and residues important for human HBP/SLBP protein stability
() and cellular localization () are indicated [11–13]. Also indicated is Trp75 essential for the interaction of HBP/SLBP
protein with CTIF () [25].
[34,39,40]. The RBD and a domain located immediately to the C-
terminal side of the RBD important for histone mRNA processing
are not affected by alternative splicing [34,39,41]. Residues in the
N- and C-terminal regions flanking the RBD of HBP/SLBP con-
tribute to the high sequence – and structure – specificity of RNA
binding. However, removing these regions does not actually ab-
olish RNA binding nor does it allow for binding to RNA with
any major deviations from the hairpin RNA consensus sequence
[34,40].
Exons 2 and 3 encode elements in Xenopus SLBP1 known
to be important for histone mRNA translation, and elements in
human HBP/SLBP essential for its cellular localization and sta-
bility (Figure 4). The region Lys65–Gln82 of Xenopus SLBP1 is
important for translation and the interaction with SLIP1, a factor
specifically involved in translation of histone mRNA [21,22,24].
The alignment of the N-terminal sequences of human, chicken
and zebrafish HBP/SLBP and Xenopus SLBP1 indicates that this
region encoded by exon 3 is conserved in chicken, zebrafish
and human proteins (Figure 4). We have shown previously that
Xenopus SLBP1 lacking the exon 3 region is unable to stimulate
cap-dependent translation initiation [22]. Furthermore, replacing
Trp75 with Ala in the human protein disrupts an interaction with
the CTIF [25]. CTIF localises to the nuclear envelope and binds
to the CBP80 in the mRNA being exported, and is instrumental
in recruiting translation initiation factors and the 40S ribosomal
subunit to mRNA [26]. Thus, there is evidence implicating this
HBP/SLBP region in a pioneer round of translation mediated
by cap-binding proteins as well as eIF4E-dependent translation
initiation and indicating that HBP/SLBP lacking this region is
unable to fulfil this function. Interestingly, overexpression of
HBP/SLBP with Ala75 also reduces the efficiency of replication
stress-induced histone mRNA decay. It has been reported earlier
that histone mRNA translation and mRNA decay are linked and
this observation points towards a key role for HBP/SLBP in these
processes [25,42].
The sequences Thr61Thr62Pro63 and Lys96Arg97Lys98Leu99 are
important for the degradation of human HBP/SLBP upon exit
from S phase. Thr61Thr62Pro63 encoded by exon 3 is a target for
cyclin-dependent phosphorylation, and Lys96Arg97Lys98Leu99
encoded by exon 4 is a consensus cyclin binding site [12,13].
Cyclin-mediated phosphorylation of two threonine residues in
the Thr61Thr62Pro63 sequence at the end of S phase is required
for proteasome-mediated degradation of HBP/SLBP [10,12]. The
sequence Lys96Arg97Lys98Leu99 has also been implicated in the
nuclear localization of HBP/SLBP [13]. This element, together
with the sequence Arg31Lys32Arg33Arg34 in exon 2 and a third se-
quence element close to the C-terminus Lys246Val247Arg248His249,
is involved in nuclear import of HBP/SLBP mediated by Im-
portin α/Importin β [13]. These elements are essentially con-
served between human, chicken and zebrafish HBP/SLBP and
Xenopus SLBP1. Finally, in addition to phosphorylation of Thr61
and Thr62, phosphorylation of Ser20 and Ser23 encoded by exon
1 and 2 has recently been connected to the destabilization of
human HBP/SLBP by ubiquitination [11]. Despite the apparent
importance of this region it is poorly conserved.
Alternative splicing produces HBP/SLBP isoforms
with different cellular localizations
We decided to investigate the effect of alternative splicing on
the cellular localization of HBP/SLBP. We included in this
analysis all the isoforms encoded by the splice variants de-
tected, namely HBP/SLBP, HBP/SLBPE2, HBP/SLBPE3
and HBP/SLBPE2 +E3. The subcellular localization of
HBP/SLBP has previously been examined by immunofluores-
cence using either antibodies raised against human HBP/SLBP,
or expression of tagged HBP/SLBP from a transgene [13,43].
This has led to the view that HBP/SLBP is localised to both the
nucleus and cytoplasm during S phase.
To examine the effect that alternative splicing may have on the
localization of the generated HBP/SLBP isoforms, we prepared
constructs for the expression of the different HBP/SLBP isoforms
with an N-terminal GFP tag. The constructs were transfected into
HeLa cells and the cellular localization was analysed by confocal
microscopy. Since HBP/SLBP is normally expressed in S phase,
we synchronised HeLa cells by double thymidine block and spe-
cifically examined the localization of these proteins in S phase
cells. Figure 5 shows that GFP-HBP/SLBP protein was detected
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Figure 5 Alternative splicing alters the subcellular localization of HBP/SLBP
S phase HeLa cells synchronised by dT block and expressing the indicated GFP–HBP/SLBP isoforms were prepared and
analysed by confocal microscopy as described in Materials and Methods (S phase). For the treatment with HU, S-phase
cells were supplemented with HU and incubated further for 1 h ( + HU). Images of typical cells observed in each case are
shown. DAPI staining was used to detect nuclei and protein localization was detected by GFP fluorescence. The subcellular
localization of the GFP–HBP/SLBP isoform fusions were categorised as nuclear (nuclear localization of GFP–HBP isoform
fusions with only background levels observed in the cytoplasm) or nuclear and cytoplasmic (nuclear localization of GFP–HBP
isoform fusions and higher than background levels observed in the cytoplasm). The bar graph summarises the analysis of
protein localization. n indicates the number of cells analysed. The percentages of cells in each category are represented
as a proportion of stacked bars totalling 100 %. GFP staining was enhanced using ImageJ software to detect low levels of
cytoplasmic HBP/SLBP above background fluorescence. The scale bar is 20 μm.
in both the nucleus and cytoplasm of the majority of cells (85.6 %
nuclear and cytoplasmic staining). In light of previous obser-
vations by others, this was an anticipated result [13,43]. Sim-
ilarly, GFP–HBP/SLBPE2 and GFP–HBP/SLBPE2 +E3
proteins were detected in both the nucleus and cytoplasm in the
majority of cells (87 % nuclear and cytoplasmic staining). On
the other hand, GFP–HBP/SLBPE3 was predominantly detec-
ted in the nucleus (92.8 %), and its cytoplasmic staining was
weak and concentrated on regions close to the nucleus. We also
examined whether the localization of the GFP-fusion proteins is
dependent on histone mRNA as this has been reported to con-
tribute to the cytoplasmic localization of HBP/SLBP [13]. We
treated the cells with HU, which causes rapid degradation of
histone mRNA (e.g. see Figure 2) and found that this did not
fundamentally affect the subcellular localization of the fusion
proteins (Figure 5). Together, this indicates that the localization
we detected is a property of the various HBP/SLBP proteins
independent of histone gene expression.
In conclusion, our results indicate that the cellular local-
ization of HBP/SLBP isoforms observed here is an intrinsic
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property of these proteins. While HBP/SLBP, HBP/SLBPE2
and HBP/SLBPE2 +E3 localise to both the nucleus and cyto-
plasm, HBP/SLBPE3 localises predominantly to the nucleus.
DISCUSSION
The histone mRNA-binding protein HBP/SLBP is a key reg-
ulator of the post-transcriptional control of histone gene ex-
pression and is instrumental in ensuring that histone protein
synthesis only takes place in S phase, allowing for the pack-
aging of newly replicated DNA. HBP/SLBP is a key com-
ponent of the machinery processing histone mRNA 3′ ends
and functions in cap-dependent translation initiation of histone
mRNA. The expression of HBP/SLBP is cell cycle regulated
whereby its protein synthesis is limited to S phase by an un-
clear mechanism controlling HBP/SLBP mRNA translation [9].
Here, we report the identification of alternative splice variants
of human HBP/SLBP mRNA (Figure 1C), that lack exon 2
(HBP/SLBPE2) or exon 3 (HBP/SLBPE3) or both exons 2
and 3 (HBP/SLBPE2 +E3) and the detection of an additional
smaller HBP/SLBP protein isoform (Figure 1D). Our data indic-
ate that alternative splice variants are rare in S-phase cells but are
enriched in HeLa cells subjected to replication stress conditions.
It is well known that under replication stress conditions, sig-
nalling involving checkpoint kinases leads to the arrest of the
production of replication-dependent histone proteins at various
different levels of their metabolism [27,28,44]. We found that
alternative splicing of HBP/SLBP is specifically enhanced under
replication stress and that notably it does not appear that replica-
tion stress conditions induced widespread changes to alternative
splicing (Figures 1 and 2). We observed that levels of alternat-
ively spliced HBP/SLBP transcripts decrease again after recovery
from replication stress (Figure 2). This, together with the obser-
vation that alternative splicing is abrogated by the presence of
the checkpoint kinase inhibitor caffeine (Figure 3), indicates that
alternative splicing of HBP/SLBP is a physiological, checkpoint-
mediated response that may contribute to the down-regulation
of histone gene expression observed under replication stress
conditions.
Our observations indicate that checkpoint kinases also act to
increase the alternative splicing of HBP/SLBP mRNA, a key
regulator of histone mRNA metabolism. The increase in altern-
atively spliced HBP/SLBP transcripts under replication stress
conditions is likely to have a physiological meaning for the cell.
It has been shown that under replication stress conditions, the
histone mRNAs disappear whereas the HBP/SLBP protein levels
remain unaffected [43]. Now with our results, it is clear that
the expression of HBP/SLBP is linked to DNA replication in a
previously unappreciated manner. Of course, this finding begs
the question as to why exactly this happens and what function
these alternative HBP/SLBP proteins might serve in cells exposed
to replication stress conditions. Alternative splicing of exons 2
and/or 3 leads to the inclusion or omission of sequences important
for HBP/SLBP localization and stability, and for the HBP/SLBP
function in histone mRNA metabolism such as its role in histone
mRNA translation (Figures 1 and 4) [12,13,22,23,34]. Removal
of these sequences is expected to create HBP/SLBP isoforms
with different properties.
It has been reported that HBP/SLBP localises predomin-
antly to the nucleus at the beginning and end of S phase
[13]. During S phase, it is also found in the cytoplasm. Us-
ing GFP-tagged HBP/SLBP isoforms we observed that al-
ternative splicing radically affects the cellular localization of
HBP/SLBP isoforms. Similar to endogenous HBP/SLBP, full-
length GFP-tagged HBP/SLBP and the isoforms HBP/SLBPE2
and HBP/SLBPE2 +E3 localised to both the nucleus and
cytoplasm (Figure 5). Exon 2 contains one of three elements
previously identified as important for nuclear import mediated
by Importin α/β, the others being located in exons 4 and 8
[13]. The observation that loss of the region encoded by exon
2 does not affect localization is in agreement with the observa-
tion that the omission of at least of two, but even better a lack
of all three elements was required for a significant loss of nuc-
lear localization [13]. In contrast, the HBP/SLBPE3 isoform
localised predominantly to the nucleus, with only limited cyto-
plasmic staining. The reason for the reduction in cytoplasmic
localization of HBP/SLBPE3 is not clear. Perhaps, the join-
ing of exons 2 and 4 enhances the nuclear localization signal by
bringing residues encoded by exon 2 such as Arg55Arg56 closer
to Lys96Arg97Lys98Leu99. Alternatively, exon 3 may be important
for nuclear export and loss of this sequence may result in retention
of the HBP/SLBPE3 protein in the nucleus. The observation
that HBP/SLBPE2 +E3 protein lacking exon 2 sequence in
addition to exon 3 is found in the nucleus and cytoplasm sug-
gests that there may be complex interactions between sequences
in this region of the protein which are important for cellular
localization.
The replication stress-induced production of a predominantly
nuclear HBP/SLBP isoform may contribute to the observation
by others that HBP/SLBP is localised in the nucleus in cells
treated with HU [20,43]. This observation led to the proposal
that co-export of HBP/SLBP with histone mRNA from the nuc-
leus contributes to the cytoplasmic localization of HBP/SLBP
observed during S phase and that relocation of HBP/SLBP into
the nucleus under replication stress conditions is linked to the
degradation of histone mRNA. In our hands, treatment with HU
did not abolish the cytoplasmic localization of HBP/SLBP. It
may be that analysis by confocal microscopy allows for the
clearer detection of cytoplasmic HBP/SLBP, and, as HBP/SLBP
is overexpressed we may detect the underlying subcellular dis-
tribution of HBP/SLBP independent of the presence of histone
mRNA.
HBP/SLBP binds to histone mRNA and plays a role in all
aspects of its metabolism, from RNA 3′ processing and possibly
histone mRNA export in the nucleus to translation initiation and
histone mRNA degradation in the cytoplasm. It promotes these
processes by undergoing protein–protein interactions that pro-
mote the recruitment of factors involved in these processes. All
of the HBP/SLBP isoforms still contain the well characterised
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residues necessary for the role of HBP/SLBP in histone pre-
mRNA processing. For example, the residues necessary to inter-
act with ZFP100 are present in all isoforms [14]. It has been pro-
posed that HBP/SLBP acts in histone mRNA export [20] and an
attractive hypothesis is that the HBP/SLBPE3 isoform inhibits
export of histone mRNA from the nucleus since it is predom-
inately localised to the nucleus (Figure 5). Therefore we tested
the various HBP/SLBP isoforms in a nuclear export assay [45].
However, we failed to detect any significant activity of either
the wild-type or the isoform versions (results not shown), and
thus were unable to test this hypothesis. Furthermore, exon 3 in
particular contains an element important for binding to CTIF,
SLIP1, eIF3 and PAIP1 [22,25,46]. These factors are important
for translation initiation and we have shown that loss of this re-
gion impedes any role of HBP/SLBP in translation [22,23]. In
a recent report the interaction between zebrafish SLIP1 and the
HBP/SLBP element important for translation (Figure 4), termed
the SBM (SLIP1-binding motif) by the authors, has been char-
acterised [47]. This motif has been found in two other proteins,
the translation factor eIF3g and the nuclear export factor DBP5,
and the binding of these proteins to SLIP1 was confirmed experi-
mentally. SLIP1 forms homodimers, and the authors propose that
these homodimers may recruit factors such as eIF3g or DBP5 to
histone mRNA via an interaction with HBP/SLBP. It was also
proposed that the recruitment of CTIF to histone mRNA is in
the form of a SLIP1–CTIF heterodimer, although other evidence
indicates that the interaction between HBP/SLBP and CTIF can
be SLIP1 independent [25]. Therefore producing an isoform of
HBP/SLBP that is unable to interact with key translation factors,
HBP/SLBPE3, may serve as a further level of regulation to
repress the production of histone proteins under replication stress
conditions.
It should be noted that there are also known interactions which
have not yet been mapped. For instance, HBP/SLBP interacts
with Pin1, which facilitates RNA binding and also the ultimate
degradation of HBP/SLBP itself. HBP/SLBP has also been found
to interact with UPF1, a factor involved in mRNA decay [11,27].
It is possible that alternative splicing leads to the production
of HBP/SLBP proteins that are unable to make critical interac-
tions with other proteins and thus interferes with the function
of HBP/SLBP in various parts of histone mRNA metabolism.
This might include the synthesis of HBP/SLBP isoforms lacking
elements for its normal regulation or localization, thus making it
unable to participate in histone mRNA regulation. Alternatively,
it may also create proteins that are able to undergo new, not yet
identified interactions that do not normally occur in undisturbed
S-phase cells. It would have been interesting to explore the effects
of the absence of these sequences on the structure of HBP/SLBP;
however, to date no structure is available for full-length human
HBP/SLBP.
In conclusion, our findings indicate that HBP/SLBP activity
is not only controlled by cell-cycle regulated expression but also
by alternative splicing of HBP/SLBP mRNA. This leads to the
production of significant levels of transcripts lacking sequences
coding for elements involved in the function of HBP/SLBP pro-
tein in the control of histone gene expression. We propose that this
is a newly identified layer of the control of histone gene expres-
sion acting during S phase. Our results indicate that this involves
components of the checkpoint response. It will be interesting
to explore the molecular mechanisms that control HBP/SLBP
mRNA splicing and to investigate the functions of the HBP/SLBP
isoforms produced under replication stress conditions.
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